口服抗凝药与肾损害
Journal of Clinical Cardiology(2018)
Abstract
口服抗凝药包括维生素K拮抗剂和新型口服抗凝剂(NOACs).近年来陆续有华法林和NOACs导致急性肾损伤(AKI)的报道,被称为抗凝剂相关肾病.其临床表现为应用抗凝剂后短时间内发生AKI,不能用其他原因解释,伴或不伴肉眼血尿;改善凝血后进行肾穿刺检查,组织学显示弥漫性肾小球出血,可见到肾小管内红细胞管型.本文综述口服抗凝剂的作用机制、药代动力学特点及其肾损害的特点、发病机制、危险因素、治疗原则和预后,希望能为临床安全用药提供帮助.
MoreAI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined